Corticosteroids: Options in the era of steroid-sparing therapy

被引:119
作者
Del Rosso, J
Friedlander, SF
机构
[1] Univ Nevada, Sch Med, Dept Dermatol, Las Vegas, NV 89154 USA
[2] Univ Calif San Diego, Sch Med, Dept Med Dermatol, San Diego, CA 92103 USA
[3] Univ Calif San Diego, Sch Med, Dept Pediat, San Diego, CA 92103 USA
[4] Childrens Hosp, San Diego, CA USA
关键词
D O I
10.1016/j.jaad.2005.04.030
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Topical corticosteroids remain the most commonly used topical treatments for inflammatory dermatoses, including psoriasis and atopic dermatitis. Topical corticosteroids are available in a variety of vehicle-screams, ointments, lotions, gels, and, more recently, foam. The vehicle used can substantially affect the individual agent's clinical action, potency, and acceptability to the patient. Moreover, some vehicles are better suited for specific body areas. Selection of the appropriate product should be determined by area of usage, physician experience, cost, and patient preference, particularly regarding vehicle. Although topical corticosteroicts are associated with several side effects, including skin atrophy, telangiectases, pUrpura, and striae formation, appropriate usage can minimize these Occurrences. judicious use includes short-term, appropriate application as initial monotherapy or in combination strategies with other therapeutic agents that ideally possess complementing mechanisms of action. Examples include pulsing with high-potency Z, topical corticosteroids and combination regimens with other topical agents such as topical calcineurin inhibitors, calcipotriene, or tazarotene. Appropriate education of patients and caregivers alike will facilitate the optimal use of these medications.
引用
收藏
页码:S50 / S58
页数:9
相关论文
共 59 条
[1]   Parental knowledge of topical therapies in the treatment of childhood atopic dermatitis [J].
Beattie, PE ;
Lewis-Jones, MS .
CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2003, 28 (05) :549-553
[2]  
BERGER M, 1975, PEDIATRICS, V55, P459
[3]  
Bruner Christine R, 2003, Dermatol Online J, V9, P2
[4]  
CALLIS KP, 2003, THERAPY MODERATE SEV, P29
[5]   Clinical evidence - Atopic eczema [J].
Charman, C .
BMJ-BRITISH MEDICAL JOURNAL, 1999, 318 (7198) :1600-1604
[6]   Topical corticosteroid phobia in patients with atopic eczema [J].
Charman, CR ;
Morris, AD ;
Williams, HC .
BRITISH JOURNAL OF DERMATOLOGY, 2000, 142 (05) :931-936
[7]   CORRELATION OF THE VASOCONSTRICTION ASSAY AND CLINICAL ACTIVITY IN PSORIASIS [J].
CORNELL, RC ;
STOUGHTON, RB .
ARCHIVES OF DERMATOLOGY, 1985, 121 (01) :63-67
[8]  
CORNICK M, 1992, NOTTINGHAM FR STUD, V31, P1
[9]  
Correale CE, 1999, AM FAM PHYSICIAN, V60, P1191
[10]  
DELROSSO JQ, 2004, 62 ANN M AM AC DERM